STOCK MARKET Wockhardt shares surge 3% after positive CDSCO panel nod for new antibiotic Zaynich Mar 30, 2026
BUSINESS Wockhardt’s Zaynich receives favourable recommendation for Gram-negative infections treatment Mar 30, 2026
CORPORATES Wockhardt files Marketing Authorisation Application to EMA for antibiotic WCK 5222 Jan 7, 2026
Wockhardt shares surge over 8% on successful Zaynich treatment for drug-resistant infections Dec 16, 2024
Wockhardt Q2 FY25 Results: Revenue up 7.43% YoY to Rs 809 crore, Net Loss widens to Rs 22 crore Nov 13, 2024
Wockhardt files Insulin Aspart injection with DCGI, reinforcing diabetes management commitment Oct 16, 2024